We are pleased to announce that we have started delivering highly sensitive medical and scientific services for one of the leading pharma companies in the world. We are continuing our drive to simplify & enrich operating processes and communication(s) with physicians, patients and regulatory authorities around the world.

For a full copy of our press release, please see the following link: